Clinical Trial Update: A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ropinirole immediate-release with ropinirole prolonged-release in advanced Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole (immediate-release) (ropinirole)
• Ropinirole prolonged-release (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED